UNAUDITED FINANCIAL RESULTS FOR Q3 AND 9 MONTHS ENDED DECEMBER 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.6 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Resonance Specialties reported strong Q3 FY26 results with revenue from operations of Rs 22.96 crores, up about 26% from Rs 18.24 crores in Q3 FY25. Profit after tax jumped roughly 125% to Rs 2.51 crores from Rs 1.12 crores, with EPS at Rs 2.18 vs Rs 0.96. For the 9-month period, revenue grew about 23% to Rs 65.77 crores and PAT rose about 65% to Rs 5.80 crores, lifting 9M EPS to Rs 5.02 from Rs 3.02. Export revenue surged to Rs 35.66 crores in 9M FY26 from Rs 22.93 crores, showing strong overseas demand. The board appointed Ms. Dhara Shah as Independent Director for 5 years and made Mr. Raj Kamal Prasad Verma the new Board Chairman, replacing Mrs. Archana Yadav whose second term ends on February 7, 2026.
The sharp acceleration in both revenue and profits, especially exports, is positive for shareholders and likely to support the stock. The clean limited review report from auditors with no qualifications adds confidence, though shareholders should await the full-year results to confirm this momentum.